Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
02/27/2003 | WO2002098865A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
02/27/2003 | WO2002079149A3 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
02/27/2003 | WO2002067675A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
02/27/2003 | US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
02/27/2003 | US20030040608 Having good hue and capable of forming images having high lightfastness |
02/27/2003 | US20030040540 Bromonitrothienyldioxanes |
02/27/2003 | US20030040518 For therapy of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons degeneration of lesioned and damaged neurons |
02/27/2003 | US20030040483 Compounds with growth hormone releasing properties |
02/27/2003 | US20030040437 Substituted pyridine herbicides |
02/27/2003 | CA2457037A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
02/27/2003 | CA2456932A1 N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides |
02/26/2003 | EP1285920A1 C10 Ester sustituted taxanes as antitumor agents |
02/26/2003 | EP1285919A1 C10 Carbonate substituted taxanes as antitumor agents |
02/26/2003 | EP1285918A1 C7 Ester substituted taxanes as antitumor agents |
02/26/2003 | EP1285653A1 Use of alpha-1L agonists in the treatment of incontinence |
02/26/2003 | EP1042297B1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
02/26/2003 | EP0971901B1 Phthalazinones |
02/26/2003 | EP0941221B1 Substituted dihydrobenzofurans as pde inhibitors |
02/26/2003 | EP0938483B1 Muscarinic antagonists |
02/26/2003 | EP0798295B1 Novel amidinonaphthyl derivative or salt thereof |
02/26/2003 | CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
02/26/2003 | CN1399515A Insecticidal and acaricidal agents |
02/26/2003 | CN1102144C Noval pyrimidine derivatives and prepn. processes thereof |
02/25/2003 | US6525215 HIV protease inhibitors |
02/25/2003 | US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
02/25/2003 | US6525099 N-substituted sulfonamide derivatives |
02/25/2003 | US6525080 Thiazoline acid derivatives |
02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
02/25/2003 | US6525059 Substituted pyrazoles as p38 kinase inhibitors |
02/25/2003 | US6525050 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive |
02/25/2003 | US6525042 Sulfonyl derivatives |
02/25/2003 | US6524382 Pigmented vitreous material |
02/20/2003 | WO2003014255A1 Fluorescent diketopyrrolopyrrole analogues |
02/20/2003 | WO2003014111A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
02/20/2003 | WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
02/20/2003 | WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
02/20/2003 | WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors |
02/20/2003 | WO2003014075A2 Novel gamma secretase inhibitors |
02/20/2003 | WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
02/20/2003 | WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors |
02/20/2003 | WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
02/20/2003 | WO2002060874A8 Potassium channel inhibitors |
02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
02/20/2003 | US20030036655 2-(substituted-phenyl)amino-imidazoline derivatives |
02/20/2003 | US20030036557 Heterocyclo-substituted imidazoles for the treatment of inflammation |
02/20/2003 | US20030036552 Novel compounds |
02/20/2003 | US20030036551 Aryl or heteroaryl-substituted tetrahydroisoquinoline derivates possess anti-convulsant activity and are therefore believed to be useful in the treatment and/or prevention of many diseases |
02/20/2003 | US20030036544 Pesticidal triazine-derivatives |
02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
02/20/2003 | CA2455861A1 Sulfonamide derivatives as gamma secretase inhibitors |
02/20/2003 | CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
02/19/2003 | EP1283837A1 New thiochromane derivatives and their use as thrombin inhibitors |
02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
02/19/2003 | EP1123290B1 3-(substituted phenyl)-5-thienyl-1,2,4-triazole compounds with activity against whitefly |
02/19/2003 | EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
02/19/2003 | EP0917530B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
02/19/2003 | EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors |
02/19/2003 | EP0690867B1 Taxanes having furyl or thienyl substituted side-chain |
02/19/2003 | EP0687260B1 Process for the preparation of 9-desoxotaxanes |
02/19/2003 | CN1398298A Non-endogenous, constitutively activated human G protein-coupled receptors |
02/19/2003 | CN1398264A 吲哚-3-基衍生物 Indol-3-yl derivative |
02/19/2003 | CN1398252A Dehydroamino acids compounds |
02/19/2003 | CN1397550A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
02/18/2003 | US6521660 3′-alkyl substituted taxanes and pharmaceutical compositions containing them |
02/18/2003 | US6521657 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
02/18/2003 | US6521653 Microbicidal benzotriazoles |
02/18/2003 | US6521652 Thiazoline acid derivatives |
02/18/2003 | US6521650 Amines as pharmaceutical agents |
02/18/2003 | US6521643 Pyridine compounds and their pharmaceutical use |
02/18/2003 | US6521638 2,3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
02/18/2003 | US6521629 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia |
02/18/2003 | US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
02/18/2003 | US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
02/18/2003 | US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
02/18/2003 | US6521618 Antineoplastic agents, agents for treatment of osteoporosis and polycystic kidney disease |
02/18/2003 | US6521614 N-(amidinophenyl)cyclourea analogs as factor Xa inhibitors |
02/18/2003 | US6521603 Fungicides for the control of take-all disease of plants |
02/18/2003 | CA2264508C Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
02/13/2003 | WO2003011872A1 Platelet adp receptor inhibitors |
02/13/2003 | WO2003011858A1 Substituted isoindoles and e use thereof |
02/13/2003 | WO2003011853A1 6-aryl-4-aminopicolinates and their use as herbicides |
02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
02/13/2003 | WO2003011848A1 Benzoheterocycles as lipoxygenase inhitibors |
02/13/2003 | WO2003011841A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
02/13/2003 | WO2003011839A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
02/13/2003 | WO2003011833A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
02/13/2003 | WO2003011830A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
02/13/2003 | WO2003011297A1 N3-substituted 6-anilinopyrimidines and methods to treat gram-positive bacterial and mycoplasmal infections |
02/13/2003 | WO2003011287A1 Pyrazolon derivatives as inhibitors of gsk-3 |
02/13/2003 | WO2002040462A3 Cysteine protease inhibitors |
02/13/2003 | US20030032811 Sulfonyltriazol derivatives and their use for combating micro-organisms |
02/13/2003 | US20030032779 Estrogen receptor ligands |
02/13/2003 | US20030032660 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |